Sponsor study identifier
interventional
25
1 country
2
Study Start
February 6, 2023
Actual (reported)Primary Completion
October 10, 2023
Actual (reported)Study Completion
December 5, 2023
Actual (reported)The purpose of this study is to assess the clinical efficacy of fractional CO2 laser-assisted delivery of a topically applied anesthetic to the perceived pain during filler injection.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 5, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 6, 2023
Actual (reported)February 6, 2023
Actual (reported)February 17, 2023
Actual (reported)October 10, 2023
Actual (reported)December 5, 2023
Actual (reported)Pain-Anesthetic effect of AFL
Pain evaluation of the injected filler, with a VAS (0 to 10)
immediately after the intervention/procedure
This test region (right or left cheek) will be pretreated with a fractional carbon dioxide laser (ablative fractional laser; AFL) with a 100 μm spot at 5% density and a pulse energy of 2.5 mJ/microbeam, single pulse at t0 in a operator- and subject- blinded fashion. A lidocaine and tetracaine mixture cream will be applied at each cheek at t1.Ten minutes after cream application (incubation time), the facial filler injections will be performed. Interventions: AFL Device: AFL Drug: anesthetic mixture cream
A pass with the same fractional carbon dioxide laser with a 100 μm spot at 5% density and a pulse energy of 2.5 mJ/microbeam, single pulse will be given at the area right adjacent to the test region on the other to the intervention cheek ("sham AFL") at t0 in a operator- and subject-blinded fashion. A lidocaine and tetracaine mixture cream will be applied at each cheek at t1.Ten minutes after cream application (incubation time), the facial filler injections will be performed. Interventions: sham AFL Device: sham AFL Drug: anesthetic mixture cream
Hyaluronic acid will be injected on the cheek, based on the aesthetic evaluation of the face.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Plastic Surgery Department
Ioannina, Greece
Swan Clinic
Ioannina, Greece
25 participants (actual enrollment reported by the registry).
First Submitted
February 6, 2023
First Posted
February 17, 2023
Study Start
February 6, 2023
The Fuel and Rhythm (FAR) Phase 2 Study
Contact the study team to confirm eligibility.
Primary Completion
October 10, 2023
Actual (reported)Study Completion
December 5, 2023
Actual (reported)Last Updated
May 8, 2024
Record last verified: 2024-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: